June 13, 2021, 9:03 a.m.
(The Wall Street Journal) Controversy surrounding Biogen’s Aduhelm could ignite political firestorm over high drug prices, but investors should look past any D.C. drama.
Login to grade this article.
June 13, 2021, 9:03 a.m.
(The Wall Street Journal) Controversy surrounding Biogen’s Aduhelm could ignite political firestorm over high drug prices, but investors should look past any D.C. drama.
Login to grade this article.